MedTrace Logo

High Velocity Resistance Training Versus Otago Exercise Training on Falling Risk in Elderly

NCT07204808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-22

No results posted yet for this study

Summary

The study aim is to find out the difference between applying the otago exercise training versus high velocity resisted training on risk of fall in elderly. There will be no significant difference between the effect of otago exercise program versus high velocity resisted training on risk of fall in elderly . 40 Old aged persons of both sex their age \>65 years and have risk of falling will be recruited in this study.

Conditions

  • Falling Risk

Interventions

DEVICE

High velocity resistance training + Otago Exercise Program

Participants who will be randomized to the HVRT will receive an exercise program targeting the lower limbs, to be performed twice a week for 8 weeks. Participants will be instructed to perform the exercises in a rapid and explosive manner such that all repetitions for each shortening phase will be performed as quickly as possible while the lengthening phase of the muscle will be controlled over 2-3 s The exercise will be done (bilateral leg press, step up, sit to stand, calf raise). The 8 weeks will be divided in three phases . OEP consists of strengthening and balance exercises. Strengthening of ankle plantar and dorsiflexors, knee extensors and flexors, and hip abductors will be focused in this program. Ankle weight cuffs (1-3 kg) provide resistance for hip and knee exercises. The ankle plantar and dorsiflexors will be strengthened by performing heel and toe raise . plantar and dorsiflexors will be strengthened by performing heel and toe

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Tamer Ibrahim Abo Elyazed, Professor · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07204808 on ClinicalTrials.gov